Updated on 16 October 2026
Competitive Patent Early Warning & Landscaping: An Enterprise-Grade SaaS Service
CEO at Intellisemantic
Rivoli, Italy
About
We provide a dedicated, enterprise-grade SaaS platform that bridges the gap between R&D innovation and Intellectual Property (IP) management. In the fast-evolving medical device and healthcare sectors, staying ahead of competitor filings is critical.
Our solution acts as a company-specific repository and an early-warning system, automatically monitoring third-party patent applications. It allows life sciences companies and medical corporations to systematically track technological trends, evaluate competitor strategies, and safeguard their own R&D pipelines from infringement risks before investing significant capital.
The Problem Solved
-
Blind Spots in R&D: Mitigates the risk of overlapping research by providing an early warning of third-party patent applications that could impact product development timelines.
-
Complex Competitor Tracking: Simplifies the overwhelming task of analyzing complex global patent trends and technology landscapes.
-
Siloed Internal Communication: Resolves the traditional disconnect between R&D engineers (tech experts) and IP managers (legal experts) by providing a unified collaborative workspace.
Key Features & Innovation
-
Scalable Private Repository: Supports dedicated hosting of 10,000+ competitive patents of interest (expandable on demand).
-
Dual-User Architecture: Tailored interfaces and workflows specifically built for two distinct user categories: IP Managers and R&D Experts.
-
Customizable Categorization: Allows companies to organize patents by custom criteria (e.g., specific medical technology, clinical application, or competitor) to facilitate global trend analysis.
-
Semantic Retrieval & Search: Empowers users to find relevant prior art and related patents quickly without needing complex Boolean strings.
-
Collaborative Tools: Features native annotation, scoring, and evaluation tools to streamline communication and speed up decision-making between legal and technical teams.
Target Audience & Ideal Partners
Our primary targets are corporate enterprises and medium-to-large medical organizations systematically engaged in medical device development, pharmaceutical R&D, and biotechnology patenting.
Looking for
- Buyer
Applies to
- E-HEALTH
- INDUSTRIAL BIOTECHNOLOGY
- MICRO- AND NANOTECHNOLOGY
- ROBOTICS AND AUTOMATION
- THERAPEUTIC AREA
Organisation
Similar opportunities
Service
CONTRACT DEVELOPMENT ORGANIZATION – CDO
- VALUE CHAIN
- LIFE SCIENCE
- Certification
- Technology Transfer
- Innovation management
- Research & Development
Elbekkay Tajmout
Co-founder & Managing Director & COO at ORIOS LifeSciences
Velizy-Villacoublay, France
Service
ISO 13485 Certified Medical Mechatronics Innovation – From Concept to Serial Production
- Other
Zsuzsanna Király-Kövesi
Sales and Marketing Specialist at Mediagnost Kft
Budapest, Hungary